BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 21851897)

  • 1. Transfemoral aortic valve implantation new criteria to predict vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
    Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
    J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
    Fink N; Segev A; Barbash I; Bogdan A; Hamdan A; Mazin I; Maor E; Hay I; Guetta V; Fefer P
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):341-6. PubMed ID: 26010839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation.
    Buchanan GL; Chieffo A; Montorfano M; Maccagni D; Maisano F; Latib A; Covello RD; Grimaldi A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):579-83. PubMed ID: 22511470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2012 Feb; 5(2):207-14. PubMed ID: 22361606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation.
    Genereux P; Kodali S; Leon MB; Smith CR; Ben-Gal Y; Kirtane AJ; Daneault B; Reiss GR; Moses JW; Williams MR
    JACC Cardiovasc Interv; 2011 Aug; 4(8):861-7. PubMed ID: 21851899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
    Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement.
    Sedaghat A; Sinning JM; Werner N
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E613-6. PubMed ID: 23460472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients.
    Di Mario C; Eltchaninoff H; Moat N; Goicolea J; Ussia GP; Kala P; Wenaweser P; Zembala M; Nickenig G; Alegria Barrero E; Snow T; Iung B; Zamorano P; Schuler G; Corti R; Alfieri O; Prendergast B; Ludman P; Windecker S; Sabate M; Gilard M; Witowski A; Danenberg H; Schroeder E; Romeo F; Macaya C; Derumeaux G; Maggioni A; Tavazzi L;
    EuroIntervention; 2013 Apr; 8(12):1362-71. PubMed ID: 23256965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
    Abu Saleh WK; Tang GH; Ahmad H; Cohen M; Undemir C; Lansman SL; Reyes M; Barker CM; Kleiman NS; Reardon MJ; Ramlawi B
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):135-43. PubMed ID: 26603266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of vascular complications following transcatheter aortic valve implantation.
    Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
    Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
    El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
    EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferior epigastric artery as a landmark for transfemoral TAVI. Optimizing vascular access?
    Vavuranakis M; Kalogeras K; Vrachatis D; Kariori M; Voudris V; Aznaouridis K; Moldovan C; Vaina S; Lazaros G; Masoura K; Thomopoulou S; Stefanadis C
    Catheter Cardiovasc Interv; 2013 May; 81(6):1061-6. PubMed ID: 23197467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter aortic valve implantation in patients of small body size.
    Watanabe Y; Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):272-80. PubMed ID: 23613222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation.
    Sinning JM; Ghanem A; Steinhäuser H; Adenauer V; Hammerstingl C; Nickenig G; Werner N
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1141-9. PubMed ID: 21087750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of the access during aortic valve implantation through transfemoral access.
    Alsac JM; Zegdi R; Blanchard D; Achouh P; Cholley B; Berrebi A; Julia P; Fabiani JN
    Ann Vasc Surg; 2011 Aug; 25(6):752-7. PubMed ID: 21621377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.